Association between 1-h bundle and clinical outcomes in patients with sepsis: A systematic review and meta-analysis

Shukun Hong1, Hongye Wang2, Jian Liu1

  • 1Department of Intensive Care Unit, Shengli Oilfield Central Hospital, Dongying, China; Clinical Research Center of Dongying Critical Care Medicine, Dongying, China.

PubMed

Insights

The 1-hour sepsis bundle significantly reduces short-term mortality in patients. Implementing this sepsis bundle in intensive care units (ICUs) shows promising results for improved patient survival.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Sepsis is a life-threatening condition requiring timely and effective treatment.
  • The 1-hour bundle is a set of evidence-based interventions designed for rapid sepsis management.
  • Comparing the 1-hour bundle with non-standard care is crucial for optimizing sepsis protocols.

Purpose of the Study:

  • To systematically review and meta-analyze the clinical impact of the 1-hour bundle versus non-1-hour bundle protocols in sepsis patients.
  • To assess the effect of the 1-hour bundle on short-term mortality and other clinical outcomes.

Main Methods:

  • A systematic literature search was conducted across PubMed, Ovid, Cochrane Library, and Web of Science.
  • Studies comparing the 1-hour bundle and non-1-hour bundle in sepsis patients were included.
  • The primary outcome measure was short-term mortality (in-hospital, 28-day, and 30-day).

Main Results:

  • Ten studies involving 4435 patients were analyzed.
  • The 1-hour bundle group had a lower overall mortality rate (20.8%) compared to the non-1-hour bundle group (24.7%).
  • Meta-analysis confirmed a significant reduction in short-term mortality with the 1-hour bundle (95% CI 0.69-0.84), particularly in ICU and prospective studies.

Conclusions:

  • Adherence to the 1-hour sepsis bundle can decrease short-term mortality in sepsis patients, especially within ICU settings.
  • Further high-quality randomized trials are necessary to confirm these findings, particularly for emergency department settings.
  • Critical care providers, including nurses, should integrate the 1-hour bundle into standard sepsis care protocols to improve patient outcomes.
Abstract

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
320
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
213
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
354
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
219
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
406
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
293